The project is feasibility and impact exploration of delivering supervised worker, occupation, and environment health and wellness services to offshore oil and gas platforms. Participants are engaged in a detail study to provide useful results that can serve as a response to the Wells Inquiry.

The research problem to be addressed in this project concerns the need for advanced water filtering systems that will remove traces of pharmaceuticals and estrogen hormones from drinking water. This problem is significant because these contaminants, that enter water as a result of human use, have been found in river water, treatment plant effluents and […]

Emphysema, a lung disease that millions of Canadians currently suffer from, has few safe and non-invasive options available. One of the features of emphysema is the lack of proper blood flow in the diseased lungs and this results in poor gas exchange. IKOMED Technologies Inc. and the two interns will test an innovative technology that […]

Research into brain diseases has until recently focused on neurons, but in the last several decades, blood vessels have taken a new spotlight. When blood vessels are damaged, substances can leak from the blood into the brain. Such leak can affect memory and mental health, but surprisingly, its impact on psychiatric disorders has yet to […]

Current rheumatology wait-times have been noted as reaching as high as two years for an initial assessment in the province of Newfoundland and Labrador (NL) [1]. Significant wait-times can delay diagnosis and treatment for a variety of rheumatologic conditions and highlights some of the challenges associated with a publicly funded healthcare system. Furthermore, the higher […]

The world is aging rapidly and healthy cognitive aging a major healthcare priority. Thus, a better understanding of how the brain changes with normal aging versus pathology is required. Advancements in wearable technologies may allow the assessment of brain function with greater ease, accessibility, and at a lower cost, as compared with traditional neuroimaging techniques. […]

The cost of developing new drugs is now widely acknowledged by industry leaders as prohibitive, with some estimates now in excess of $ 5B per drug. It is imperative that new approaches are developed to mitigate the cost and time required to bring new drugs to market. To help achieve this, we contend that new […]

COPD is a common inflammatory lung condition that is characterized by airflow limitation and symptoms of cough and shortness of breath. Globally, it affects 384 million people and is responsible for ~4-7% of all deaths. Longitudinal genome-wide association studies (GWAS) are needed to unravel the molecular determinants of dynamic quantitative traits underlying COPD, such as […]

Physiotherapy is a type of rehabilitation that aims to restore a patient’s quality of life after an injury, surgery, or stroke by improving their mobility. Through prescribed exercises and specialized equipment, physiotherapy helps the patient to regain their muscle strength, range of motion, and natural movement. Unfortunately, only rudimentary tools are available to the therapists […]

We are at the era of precision medicine and dentistry; however, currently there have been no attempts for personalized dental implant design and material selection that take into account variations in individuals’ anatomy, oral microbiome, saliva properties, and mechanical requirements. The overall objective of this MITACS project is to utilize a multidisciplinary approach to explore […]

Managing daily life can be overwhelming when living with low income, mental illness, addiction, and social isolation/discrimination. When crises occur, intergenerational cycles of trauma can result. Social support and strength can be found in families and support systems, but these are often not ideal. This research project will result in a measurement of resiliency in […]

Alzheimer’s disease (AD) is the most common neurodegenerative disorder. SignalChem LifeSciences Corp. recently developed a potent small molecule inhibitor (SLC-0149) for targeting CAIX, a hypoxia inducible gene, in the application of treating cancers. Since hypoxia has been implicated as a factor to facilitate AD development, this study aims to explore the potentiality of applying SLC-0149 […]